Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
  • Analysts at Baird initiated coverage on Nutanix Inc (NASDAQ: NTNX) with an Outperform rating. The price target for Nutanix is set to $37. Nutanix shares fell 0.77 percent to $30.00 in pre-market trading.
  • Analysts at Canaccord Genuity initiated coverage on Hecla Mining Company (NYSE: HL) with a Hold rating. Hecla Mining shares rose 1.39 percent to $5.85 in pre-market trading.
  • Analysts at Argus Research initiated coverage of Arista Networks Inc (NYSE: ANET) with a Buy rating. Arista Networks shares fell 0.04 percent to $84.00 in pre-market trading.
  • Brean Capital initiated coverage on Logitech International SA (USA) (NASDAQ: LOGI) with a Buy rating. The price target for Logitech is set to $30. Logitech shares slipped 0.79 percent to $21.31 in pre-market trading.
  • Analysts at Gabelli & Co. initiated coverage of AAR Corp. (NYSE: AIR) with a Buy rating. AAR shares rose 1.14 percent to close at $31.89 on Monday.
  • Analysts at Susquehanna initiated coverage on Hershey Co (NYSE: HSY) with a Neutral rating. Hershey shares declined 0.07 percent to close at $95.29 on Monday.
  • Analysts at Citigroup initiated coverage on Calithera Biosciences Inc (NASDAQ: CALA) with a Sell rating. The price target for Calithera Biosciences is set to $1. Calithera Biosciences shares dropped 15.25 percent to $2.50 in pre-market trading.
  • Oppenheimer initiated coverage on Nike Inc (NYSE: NKE) with a Perform rating. Nike shares fell 1.47 percent to $51.11 in pre-market trading.
  • Analysts at Chardan Capital initiated coverage on Clovis Oncology Inc (NASDAQ: CLVS) with a Sell rating. The price target for Clovis Oncology is set to $15. Clovis Oncology shares fell 7.46 percent to $29.90 in pre-market trading.
  • Goldman Sachs initiated coverage on Nutanix Inc (NASDAQ: NTNX) with a Neutral rating. The price target for Nutanix is set to $30. Nutanix shares fell 0.77 percent to $30.00 in pre-market trading.

Latest Ratings for NTNX

DateFirmActionFromTo
Mar 2019UpgradesHoldBuy
Mar 2019DowngradesOutperformMarket Perform
Mar 2019MaintainsOutperformOutperform

View More Analyst Ratings for NTNX
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AIR + ANET)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
HELEMaintains160.0
JWNMaintains32.0
DYMaintains64.0
PSTGMaintains18.0
TJXMaintains56.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Here's Why The New York Times Really Bought The Wirecutter

JMP Securities Downgrades Ariad, Cites Limited Near-Term Upside In Light Of Prescription Trends